Physician profile
Robert Maher
NPI 1326498965
$5,718.85
in general payments reported to CMS, 2019-2025
11 companies · $2,856 in 2025
The $2,856 reported for 2025 was more than what 85% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $244 · 2021: $183 · 2022: $244 · 2023: $115 · 2024: $2,076 · 2025: $2,856.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,213 · Education: $1,000 · Food and Beverage: $834.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,212.71 |
| Education | $1,000.00 |
| Food and Beverage | $833.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $2,863.25 | 2024-2025 | Phasix Mesh |
| Intuitive Surgical, INC. | $2,124.27 | 2023-2025 | |
| Enterra Medical, INC. | $227.99 | 2022 | |
| Acell, INC. | $224.28 | 2019 | |
| Bolton Medical INC | $148.57 | 2021 | |
| Organogenesis INC. | $34.82 | 2021 | |
| Stryker Corporation | $29.19 | 2024-2025 | Viaflow, Graftjacket, Easyfuse |
| Integra Lifesciences Corporation | $20.05 | 2019 | |
| Medtronic, INC. | $16.50 | 2022 | |
| Kci USA, INC. | $15.00 | 2023 | Snap, 3m Cavilon, Kerramax Care |
| Solventum Corporation | $14.93 | 2024 | Promogran Prisma, Activ.A.C. |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Maher listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.